https://www.live-feeds.com/feed/philip-morris-gets-fda-nod-for-11-new-nicotine-pouchesContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/philip-morris-gets-fda-nod-for-11-new-nicotine-poucheshttps://www.live-feeds.com/feed/philip-morris-gets-fda-nod-for-11-new-nicotine-pouches#u50025Thu, 27 Aug 2026 12:15:26 +0000The US FDA has authorised 11 nicotine pouch products from Philip Morris, citing lower levels of harmful constituents. The products include the ZYN ULTRA line, which features higher nicotine content and various flavors. This authorization follows a scientific review by the agency. As a result, Philip Morris stock has stabilized and fair value estimates have edged higher based on optimism surrounding ZYN and IQOS.Why it mattersThe FDA's authorization is significant for Philip Morris as it expands its portfolio of nicotine pouches, a product category that has gained popularity in recent year https://www.live-feeds.com/feed/philip-morris-gets-fda-nod-for-11-new-nicotine-poucheshttps://www.live-feeds.com/feed/philip-morris-gets-fda-nod-for-11-new-nicotine-pouches#u47160Mon, 24 Aug 2026 05:01:02 +0000The FDA has authorized 11 new nicotine pouches from Philip Morris, including the ZYN ULTRA line. These products feature higher nicotine content and various flavors. The authorization follows a scientific review by the agency. Market reaction shows Philip Morris stock stabilizing and fair value estimates edging higher based on optimism surrounding ZYN and IQOS.Why it mattersNicotine pouches are smokeless alternatives to traditional tobacco. Regulatory approval from the FDA is required to legally market modified nicotine products in the United States.What is confirmedThe FDA authorized 11 new ni